This inventor holds 1 USPTO granted patent. Top assignee: Es Cell International Pte Ltd. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Chui-Yee Fong: Innovator in Embryonic Stem Cell Research
Introduction
Chui-Yee Fong is a prominent inventor based in Singapore, known for his groundbreaking work in the field of embryonic stem cells. His innovative research has contributed significantly to the understanding and application of stem cell technology. With a focus on undifferentiated human embryonic stem cells, Fong's work has opened new avenues for medical research and therapeutic applications.
Latest Patents
Chui-Yee Fong holds a patent related to embryonic stem cells. The patent describes methods for cultivating and propagating undifferentiated human embryonic stem cells, as well as the production of differentiated cells. This invention is particularly significant as it enables the generation of somatic differentiated cells in vitro and committed progenitor cells capable of developing into mature somatic cells. Additionally, the patent provides a purified preparation of undifferentiated human embryonic stem cells that can proliferate in vitro, along with somatic cells differentiated from these embryonic stem cells.
Career Highlights
Fong is associated with Es Cell International Pte Ltd, where he has made substantial contributions to stem cell research. His work has been pivotal in advancing the understanding of stem cell biology and its potential applications in regenerative medicine.
Collaborations
Chui-Yee Fong has collaborated with notable researchers in the field, including Martin Frederick Pera and Ariffeen Bongso. These collaborations have further enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Chui-Yee Fong's contributions to embryonic stem cell research exemplify the importance of innovation in the medical field. His patented work not only enhances our understanding of stem cells but also paves the way for future advancements in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile